Revived Wartime Resource May Soon Power Everything from Bullets to Batteries
This overlooked metal isn't just for the battlefield anymore. It's part of the future energy grid, too. This could be a rare early-stage play in a market that's heating up fast.
Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons
House Judiciary subpoenas ex-Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election.
Novartis Gets Swiss Approval For First Malaria Drug For Babies
Novartis' Coartem Baby wins Swiss approval as the first malaria drug for newborns under 5 kg, offering safer dosing and easier administration.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.
Business News Digest
AP Business Digest
House GOP clears key hurdle on Trump's big bill, pushing it closer to vote
WASHINGTON (AP) — Up all night, House Republicans voted pre-dawn Thursday to advance President Donald Trump's , recouping after GOP leaders worked almost around the clock trying to persuade skeptical holdouts as they race to send the bill to his desk by the Fourth of July deadline.
This Tiny Tech Stock Could Be the Next Big Platform Play - Ad
One under-the-radar company is embedding intelligence into everyday glass-already powering Ferraris, aircraft, and city buses with adaptive surfaces and vision systems. It's not just a product. It's a platform.
Republicans are considering changes to Trump's request for $9.4 billion in spending cuts
WASHINGTON (AP) — Senate Republicans were exploring changes Tuesday to President Donald Trump's to cancel $9.4 billion in previously approved spending targeted by his Department of Government Efficiency, signaling potential difficulties ahead of an important test vote.
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says Analyst
Ultragenyx's UX111 gene therapy faces FDA delay due to facility issues; analysts adjust price targets amid uncertain resubmission timeline.
Unveil the 365X Crypto Secret - Replay Disappearing Soon! - Ad
Only 12 hours left! Watch the replay of the "365x Return in 90 Days" crypto Workshop before it's gone. Discover Joel and Adam's 4-part system, real success stories, and how to start mirroring their trades. This is your last chance-don't miss out.
Beat the heat with these cooling gadgets and wearables
You can only sit in front of the fridge with the door open for so long.
Breakfast cereal sales declined for decades before Kellogg's sale to Italian company
Breakfast cereal could use a lucky charm.
Copper's Spiking - And This Junior Has the Grades to Match - Ad
Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.
UN says if US funding for HIV programs is not replaced, millions more will die by 2029
LONDON (AP) — Years of programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades, and provided for some of the world’s most vulnerable.
Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise
Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 with regulators.
Copper's Rally Is Back. This $31M Junior Is Sitting on a Potential Fortune - Ad
A high-grade copper-gold discovery in Quebec just delivered extremely high grade intercepts. Valuation? Just $31M. With copper breaking out, the timing here could be perfect. Get the symbol here.
Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday?
ZyVersa gains FDA approval for emergency use of VAR 200 in a rare kidney disease case; stock jumps on high trading volume and regulatory momentum.
Swiss medicines authority issues first approval for antimalarial drug for treatment of infants
GENEVA (AP) — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of lives — nearly all in Africa — each year.
Revived Wartime Resource May Soon Power Everything from Bullets to Batteries - Ad
This overlooked metal isn't just for the battlefield anymore. It's part of the future energy grid, too. This could be a rare early-stage play in a market that's heating up fast.
Obesity drug prices are dropping, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.
Rural hospitals brace for financial hits or even closure under Republicans' $1 trillion Medicaid cut
OMAHA, Neb. (AP) — Tyler Sherman, a nurse at a rural Nebraska hospital, is used to the area's aging farmers delaying care until they end up in his emergency room.
Gold Just Hit Another Record. This Junior Could Be Next. - Ad
This copper junior was the smallest company invited to a top global mining conference. With nearly 1B pounds CuEq and 50,000m of funded drilling, this story won't stay quiet for long.
Nearly 368,000 pounds of Oscar Mayer turkey bacon recalled over possible listeria contamination
Nearly 368,000 pounds of Oscar Mayer turkey bacon products are being recalled over possible contamination with , federal health officials said Wednesday.
Here's how millions of people could lose health insurance if Trump's tax bill becomes law
WASHINGTON (AP) — Roughly 11.8 million adults and children will be at risk for losing health insurance if Republicans' domestic policy package becomes a law.
China is Tightening Critical Metal Supply-Investors Wondering Who Will Step Up - Ad
This metal powers everything from munitions to batteries. But with China imposing export controls, the West is scrambling for supply. One tiny firm may control a key N. American site-and investors are watching closely.
FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls
FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare neuromuscular disease.
Severe heat waves hit Southern Europe as local authorities warn against wildfire risks
ROME (AP) — Major heat waves across Southern Europe have pushed temperatures above 40 C (104 F) in countries including Italy, Spain and Greece, as local authorities issued fresh warnings against the risk of wildfires.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
The Senate is putting Trump's big bill back on track but hurdles remain
WASHINGTON (AP) — Senate Republicans appeared Friday to push back on track after a flurry of last-minute revisions, including , but there's still a long way to go ahead of expected weekend votes.
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.
Stunning Trump Policy Unlocks Upfront Cash Payouts - Ad
The U.S. has collected $15B from Trump's tariffs - and now, thanks to Title 15, you could claim your own $100-$1,000 instant upfront cash payouts. No stocks needed. Use your phone and this income technique to collect upfront payouts now.
No Accelerated FDA Approval For Edgewise's Rare Muscular Disease Drug; Shares Fall
Edgewise reports sustained functional stability in Becker patients and selects Phase 3 dose for Duchenne after positive Phase 2 trial data.
States can cut off Medicaid funding to Planned Parenthood, the Supreme Court rules
WASHINGTON (AP) — A divided allowed states to cut off Medicaid money to Planned Parenthood in a ruling handed down Thursday amid a wider Republican-backed push to defund the country’s biggest abortion provider.
Elon's Greatest Invention... Hidden in South Memphis? - Ad
In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.
Evotec's Collaboration Sparks Hope For Acute Kidney Injury Breakthroughs
Evotec shares rise after joining NURTuRE-AKI to advance kidney disease research through molecular data integration.
Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges
Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to improve cash flow
This Tiny Tech Stock Could Be the Next Big Platform Play - Ad
One under-the-radar company is embedding intelligence into everyday glass-already powering Ferraris, aircraft, and city buses with adaptive surfaces and vision systems. It's not just a product. It's a platform.
Texas will put warning labels on some foods, but its additives list has inaccuracies
DALLAS (AP) — A new Texas law promoting the “Make America Healthy Again” agenda requires first-ever warning labels on foods like chips and candies that contain dyes and additives not allowed in other countries.
Merck's Hypertension Drug Cuts Clinical Worsening Risk In Over 70% Of Patients On Double Background Therapy
Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study outcomes.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.